• Print

The AODTS-NMDS data cubes are subsets of data from the Alcohol and Other Drug Treatment Services National Minimum Data Set (AODTS-NMDS) collection.

The cubes

Note: Cubes open in new window.

How do I use the cubes?

 
When a data cube is opened, the table shows 'Treatment services/agencies' as the default measure, by 'year and state' as default dimensions.

To add a dimension to the table, left click its icon and drag it towards the top left hand of the table.

To display an additional column dimension, wait till a left-pointing arrow appears and drop the icon. To display it as an additional row dimension, wait till a downward-pointing arrow appears and drop the icon.

To remove a dimension, right click its label in the top left hand of the table and select 'Hide <dimension>' from the menu, or you can replace the dimension by selecting 'Change <dimension> to <other dimension> from the menu.

If there are too many column and/or row headings which appear in the same screen, there are arrows that allow you to scroll through the column headings and row headings.

If you want to collate totals and present percentages of totals, right click on the table icon, where the data is displayed. This provides additional options for data presentation.  

About the cubes

Period covered

The cubes cover the period 2003–04 to 2013–14.

Counting unit

The counting unit is a 'closed treatment episode'. A closed treatment episode refers to a period of contact, with defined dates of commencement and cessation, between a client and a treatment agency. As a unit of measurement, the 'closed treatment episode' used in the AODTS-NMDS cannot provide information on the number of clients who access publicly funded alcohol and other drug treatment, nor can it provide information on the extent of concurrent, sequential or recurrent service use.

Exclusions to the collection

  • Agencies whose sole activity is to prescribe and/or dose for opioid pharmacotherapy maintenance treatment such as methadone.
  • Halfway houses and sobering-up shelters, correctional institutions, health promotion services (e.g. needle and syringe exchange programs).
  • Alcohol and drug treatment units in acute care or psychiatric hospitals that only provide treatment to admitted patients.
  • Private treatment agencies that do not receive government funding.

It should also be noted that:

  • the number of Indigenous clients may be under-counted as most Australian Government funded Indigenous substance-use services and Aboriginal health services that provide treatment for alcohol and other drug problems do not supply data under the AODTS-NMDS. In addition, at the national level a substantial percentage of clients did not state their Indigenous status (varying from 5% to 8% over time).
  • the data do not provide measures of the incidence or prevalence of alcohol or other drug abuse or dependence in the community on their own. This is because not all persons who abuse alcohol or other drugs seek treatment or seek treatment from publicly funded services.

Additional information

Across all years, the following data items in the cubes have been collapsed for confidentiality reasons:

  • Method of use for principal drug of concern—Injects data has been collapsed into the Other category.
  • Source of referral for treatment—corrections, police and court diversion data have been collapsed into the Other category.
  • Reason for cessation of treatment—drug court, imprisoned and died, have been collapsed into the Other category.

2013–14

  • Approximately 99% of in-scope treatment services submitted data to the AODTS NMDS in 2013–14. Almost all jurisdictions submitted 100% of in-scope treatment services except for Victoria (97.7%) and Queensland (99.2%). Each in-scope treatment service is required to provide information on each agency related to the service (including delivery outlets). However, some services only provide information on the main administrative centre. As a result, the number of treatment agencies may be under counted (information on the number of agencies for which data are not provided is not available).
  • Services in Western Australia are not directly comparable with other states, or previous years, because of the growth of integrated services that include government and non-government service providers.

2012–13

  • Over 90% of in-scope treatment services provided data for the AODTS NMDS in 2012–13, except for New South Wales who provided 80% of in-scope agencies; the other jurisdictions ranged from 91% in the Australian Capital Territory to 100% in Western Australia, the Northern Territory and Tasmania. Each in-scope treatment service is required to provide information on each agency related to the service (including delivery outlets). However, some services only provide information on the main administrative centre. As a result, the number of treatment agencies may be under counted (information on the number of agencies for which data are not provided is not available).
  • Geographical location data for previous years was reported using various Remoteness Area (RA) Statistical Local Area (SLA) classifications. From 2012–13 remoteness area was reported using the ABS SA2 remoteness standard. The AIHW considers the change from SLA to SA2 to be a series break when applied to data supplied for this indicator; therefore remoteness data for 2012–13 and previous years are not comparable to remoteness data for subsequent years.
  • For the 2012–13 collection, an SLK was introduced to enable the number of clients receiving treatment to be counted while continuing to ensure the privacy of these individuals receiving treatment. The SLK is constructed from information about the client’s date of birth, sex and an alpha-code based on selected letters of their name. This data is not present in the data cubes.

2011–12

  • In 2011–12, almost 90% of in-scope treatment services provided data for the AODTS NMDS; this ranged from 82% in the Australian Capital Territory to 100% in Western Australia, the Northern Territory and Tasmania.
  • The number of counselling treatment services in the Australian Capital Territory decreased between 2009–10 and 2010–11.
  • In 2011–12, the DoHA conducted a review of the processes used to collate and provide NGOTGP agencies. The review resulted in an additional 14 agencies submitting data to the 2011–12 collection.

2010–11  

  • In 2010–11, 86% of in-scope treatment services provided data for the AODTS NMDS; this ranged from 75% in the Northern Territory to 100% in Tasmania
  • The proportion of ‘not stated’ responses for injecting drug use and method of use in Queensland in 2010–11 was high (59% and 58%, respectively). Also  8% of Queensland’s episodes contained a missing principal drug of concern. This high ‘not stated’ rate was due to a one-off anomaly with the introduction of a new collection database and data entry issues related to staff training and compliance.
  • The number of counselling treatment services in the Australian Capital Territory decreased between 2009–10 and 2010–11. The ACT noted two agencies that provide the majority of counselling treatment in the ACT reported a reduced number of closed treatment episodes since 2009-10.

2009–10

  • The number of episodes shown for Tasmania in the 2009-10 annual report is an over count. Tasmania resubmitted data for 2009-10, this data is included in subsequent annual report and the data cubes.

2008–09

  • The total number of agencies and episodes for New South Wales was under-reported because of system issues for the reporting period of 2008–09. This should be kept in mind when analysing time series data.

2003–04 and 2004–05

  • Queensland Health supplied data from Queensland government AODTS agencies and from police diversion processes (all with the principal drug of cannabis and main treatment type of information and education only) but not from other non-government agencies.

2001–02 and 2002–03

  • The data specifications were significantly altered for the 2003–04 collection and data from 2001–02 to 2002–03 are not comparable with data from later years.

Accessing the AODTS-NMDS

The publications associated with these cubes may also be downloaded in full. If you require more detail than is provided in the data cubes, and are not available in the publications, we also offer a data request service. Customised tables can be provided, subject to data quality and confidentiality requirements. Please note that a fee may apply for this service.

Request a customised analysis 

If you require more information or assistance with the process, please contact the unit directly at .